Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00837590 · ClinicalTrials.gov registry record · Phase 1
Vascular Function, Endothelin, and Inflammation in Pre-diabetic Obesity Versus Lean Healthy Controls
A Phase 1 study, sponsored by Indiana University.
- Terminated
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT00837590 is a Phase 1 study that was terminated before completion, run by Indiana University. The registered enrollment target is 16 participants.
The verdict
NCT00837590, a Phase 1 study, was terminated before completion, sponsored by Indiana University.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
Aims: 1. Does inflammation contribute importantly to concurrent defects in vascular and metabolic dysfunction in human pre-diabetic obesity? 2. Are there benefits of anti-inflammatory treatment strategies in pre-diabetic obesity in the context of existing treatment with metformin? 3. Are there benefits of anti-inflammatory treatment strategies in pre-diabetic obesity in the context of existing treatment with lisinopril?
Interventions
- DRUG Chronic salsalate
- DRUG Acute Salsalate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2009-03 |
| Est. Completion | 2010-08 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00837590
The ClinicalTrials.gov registry entry for NCT00837590 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Indiana University, which has 890 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Chronic salsalate is the first listed.
NCT00837590 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00837590 about?
NCT00837590 is a clinical study titled "Vascular Function, Endothelin, and Inflammation in Pre-diabetic Obesity Versus Lean Healthy Controls". Aims: 1. Does inflammation contribute importantly to concurrent defects in vascular and metabolic dysfunction in human pre-diabetic obesity? 2. Are there benefits of anti-inflammatory treatment strategies in pre-diabetic obesity in the context of existing treatment with metformin? 3. Are there bene...
What is the current status of trial NCT00837590?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2009-03. Estimated completion is 2010-08.
What interventions are being tested in trial NCT00837590?
The interventions under investigation include: Chronic salsalate (DRUG), Acute Salsalate (DRUG).
Who is sponsoring clinical trial NCT00837590?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.